314 related articles for article (PubMed ID: 37108495)
1. Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
Kuo YC; Kou HW; Hsu CP; Lo CH; Hwang TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108495
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of gemcitabine-resistant pancreatic tumor cells.
Shah AN; Summy JM; Zhang J; Park SI; Parikh NU; Gallick GE
Ann Surg Oncol; 2007 Dec; 14(12):3629-37. PubMed ID: 17909916
[TBL] [Abstract][Full Text] [Related]
3. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
Hong SP; Wen J; Bang S; Park S; Song SY
Int J Cancer; 2009 Nov; 125(10):2323-31. PubMed ID: 19598259
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.
Quint K; Tonigold M; Di Fazio P; Montalbano R; Lingelbach S; Rückert F; Alinger B; Ocker M; Neureiter D
Int J Oncol; 2012 Dec; 41(6):2093-102. PubMed ID: 23026911
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine.
Yin T; Wei H; Gou S; Shi P; Yang Z; Zhao G; Wang C
Int J Mol Sci; 2011; 12(3):1595-604. PubMed ID: 21673909
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
Du Z; Qin R; Wei C; Wang M; Shi C; Tian R; Peng C
Dig Dis Sci; 2011 Mar; 56(3):741-50. PubMed ID: 20683663
[TBL] [Abstract][Full Text] [Related]
7. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
[TBL] [Abstract][Full Text] [Related]
8. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
10. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
[TBL] [Abstract][Full Text] [Related]
11. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
12. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer.
Zhang Z; Xu Y; Zhao C
Cancer Med; 2021 May; 10(10):3332-3345. PubMed ID: 33934523
[TBL] [Abstract][Full Text] [Related]
13. The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells.
Bhagwandin VJ; Bishop JM; Wright WE; Shay JW
PLoS One; 2016; 11(2):e0148807. PubMed ID: 26859746
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
[TBL] [Abstract][Full Text] [Related]
15. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
17. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.
Lu Y; Lu J; Li X; Zhu H; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
BMC Cancer; 2014 Feb; 14():85. PubMed ID: 24521357
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.
Avan A; Quint K; Nicolini F; Funel N; Frampton AE; Maftouh M; Pelliccioni S; Schuurhuis GJ; Peters GJ; Giovannetti E
Curr Pharm Des; 2013; 19(5):940-50. PubMed ID: 22973962
[TBL] [Abstract][Full Text] [Related]
19. JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.
Suzuki S; Okada M; Shibuya K; Seino M; Sato A; Takeda H; Seino S; Yoshioka T; Kitanaka C
Oncotarget; 2015 Jan; 6(1):458-70. PubMed ID: 25473894
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.
Zhao H; Duan Q; Zhang Z; Li H; Wu H; Shen Q; Wang C; Yin T
J Cell Mol Med; 2017 Sep; 21(9):2055-2067. PubMed ID: 28244691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]